Anterior chamber-associated immune deviation: A review of the anatomical evidence for the afferent arm of this unusual experimental model of ocular immune responses

Clinical and Experimental Ophthalmology

Volumn 33, Issue 4, 2005, Pages 426-432

  Camelo, Serge ^a   Kezic, Jelena ^a   McMenamin, Paul G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anterior chamber; Antigen presenting cells; Lymphoid organs; Soluble antigen; Tolerance

Indexed keywords

CD11B ANTIGEN; DEXTRAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; ANTIGEN;

ANTERIOR EYE CHAMBER; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AQUEOUS HUMOR FLOW; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CELLULAR IMMUNITY; CHOROID; DENDRITIC CELL; ERYTHROCYTE COUNT; EXPERIMENTAL MODEL; FLUORESCENCE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOID ORGAN; MACROPHAGE FUNCTION; MESENTERY LYMPH NODE; NONHUMAN; OPTIC NERVE; PATHOLOGICAL ANATOMY; REGULATORY T LYMPHOCYTE; REVIEW; SENSORY NERVE; ANIMAL; IMMUNOLOGY; LYMPHOID TISSUE; SPLEEN; T LYMPHOCYTE; THEORETICAL MODEL;

AFFERENT PATHWAYS; ANIMALS; ANTERIOR CHAMBER; ANTIGEN-PRESENTING CELLS; ANTIGENS; HUMANS; IMMUNE TOLERANCE; LYMPHOID TISSUE; MODELS, THEORETICAL; SPLEEN; T-LYMPHOCYTES;

EID: 26944495344     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2005.01044.x     Document Type: Review

References (50)

1. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol 1997; 158: 3557-60.
2. Kaplan HJ, Streilein JW. Do immunologically privileged sites require a functioning spleen? Nature 1974; 251: 553-4.
3. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981; 153: 1058-67.
4. Wilbanks GA, Streilein JW. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 1990; 71: 566-72.
5. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 1991; 146: 3018-24.
6. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991; 146: 2610-17.
7. Skelsey ME, Mellon J, Niederkorn JY. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 2001; 166: 4327-33.
8. D'Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology 1998; 95: 47-55.
9. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999; 190: 1215-26.
10. Wilbanks GA, Streilein JW. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 1990; 71: 383-9.
11. Niederkorn JY, Lynch MG. Reconsidering the immunologic privilege and lymphatic drainage of the anterior chamber of the eye. Transplant Proc 1989; 21: 259-60.
12. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 1996; 157: 2262-71.
13. + T cells. J Immunol 2002; 169: 5630-7.
14. Camelo S, Shanley AC, Voon AS, McMenamin PG. The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye. J Immunol 2004; 172: 5388-95.
15. Goldschneider I, Cone RE. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance. Trends Immunol 2003; 24: 77-81.
16. Wang Y, Goldschneider I, Foss D, Wu DY, O'Rourke J, Cone RE. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol 1997; 158: 2150-5.
17. Wang Y, Goldschneider I, O'Rourke J, Cone RE. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol 2001; 69: 741-6.
18. Li X, Wang Y, Urso D, O'Rourke J, Cone RE. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies. Immunology 2004; 113: 44-55.
19. Waldrep JC, Kaplan HJ. Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells. Invest Ophthalmol Visual Sci 1983; 24: 1086-92.
20. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Anti-inflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 1998; 188: 887-96.
21. Ferguson TA, Stuart PM, Herndon JM, Griffith TS. Apoptosis, tolerance, and regulatory T cells -old wine, new wineskins. Immunol Rev 2003; 193: 111-23.
22. Ferguson TA, Waldrep JC, Kaplan HJ. The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber-associated immune deviation (ACAID). J Immunol 1987; 139: 352-7.
23. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7-16.
24. Wilbanks GA, Streilein JW. The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen. Evidence that the eye acts as an antigen depot. Regional Immunol 1989; 2: 390-8.
25. Wilbanks GA, Streilein JW. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Regional Immunol 1992; 4: 130-7.
26. Knisely TL, Anderson TM, Sherwood ME, Flotte TJ, Albert DM, Granstein RD. Morphologic and ultrastructural examination of I-A+ cells in the murine iris. Invest Ophthalmol Vis Sci 1991; 32: 2423-31.
27. McMenamin PG, Holthouse I. Immunohistochemical characterization of dendritic cells and macrophages in the aqueous outflow pathways of the rat eye. Exp Eye Res 1992; 55: 315-24.
28. McMenamin PG. The distribution of immune cells in the uveal tract of the normal eye. Eye 1997; 11: 183-93.
29. Steptoe RJ, Holt PG, McMenamin PG. Major histocompatibility complex (MHC) class II -positive dendritic cells in the rat iris. In situ development from MHC class II-negative precursors. Invest Ophthalmol Vis Sci 1997; 38: 2639-48.
30. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11: 805-15.
31. Becker MD, Planck SR, Crespo S et al. Immunohistology of antigen-presenting cells in vivo -a novel method for serial observation of fluorescently labeled cells. Invest Ophthalmol Vis Sci 2003; 44: 2004-9.
32. Camelo S, Voon AS, Bunt S, McMenamin PG. Local retention of soluble antigen by potential antigen-presenting cells in the anterior segment of the eye. Invest Ophthalmol Vis Sci 2003; 44: 5212-19.
33. Camelo S, Shanley AC, Voon AS, McMenamin PG. An intravital and confocal microscopic study of the distribution of intracameral antigen in the aqueous outflow pathway and limbus of the rat eye. Exp Eye Res 2004; 79: 455-64.
34. Forrester JV, Lumsden L, Duncan L, Dick AD. Choroidal dendritic cells require activation to present antigen and resident choroidal macrophages potentiates this response. Br J Ophthalmol 2005; 89: 369-77.
35. Bill A. Basic physiology of the drainage of aqueous humor. Exp Eye Res 1977; 25: 291-304.
36. Tilney NL. Patterns of lymphatic drainage in the adult laboratory rat. J Anat 1971; 109: 369-83.
37. Abu-Hijleh MF, Scothorne RJ. Studies on haemolymph nodes. IV. Comparison of the route of entry of carbon particles into parathymic nodes after intravenous and intraperitoneal injection. J Anat 1996; 188: 565-73.
38. Hoffmann F, Zhang EP, Mueller A et al. Contribution of lymphatic drainage system in corneal allograft rejection in mice. Graefes Arch Clin Exp Ophthalmol 2001; 239: 850-8.
39. Sartor RB, Anderle SK, Cromartie WJ, Schwab JH. Localized gut-associated lymphoid Tissue hemorrhage induced by intravenous peptidoglycan-polysaccharide polymers. Infect Immun 1986; 51: 521-8.
40. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994; 1: 327-39.
41. Ferguson TA, Hayashi JD, Kaplan HJ. The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum. J Immunol 1989; 143: 821-6.
42. Streilein JW, Okamoto S, Hara Y, Kosiewicz M, Ksander B. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen. Invest Ophthalmol Vis Sci 1997; 38: 2245-54.
43. Lindsey JD, Weinreb RN. Identification of the mouse uveoscleral outflow pathway using fluorescent dextran. Invest Ophthalmol Vis Sci 2002; 43: 2201-5.
44. Gretz JE, Anderson AO, Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 1997; 156: 11-24.
45. Dullforce PA, Garman KL, Seitz GW et al. APCs in the anterior uveal tract do not migrate to draining lymph nodes. J Immunol 2004; 172: 6701-8.
46. Aichele P, Zinke J, Grode L, Schwendener RA, Kaufmann SHE, Seiler P. Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cells responses. J Immunol 2003; 171: 1148-55.
47. Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 2002; 195: 259-68.
48. Lindquist RL, Shakhar G, Dudziak D et al. Visualizing dendritic cell networks in vivo. Nature Immunol 2004; 5: 1243-50.
49. Sixt M, Kanazawa N, Selg M et al. The conduit system transport soluble antigens from the afferent lymph to the resident dendritic cells in the T cell area of the lymph nodes. Immunity 2005; 22: 19-29.
50. Steptoe RJ, Holt PG, McMenamin PG. Origin and steady-state turnover of major histocompatibility complex class II-positive dendritic cells and resident-tissue macrophages in the iris of the rat eye. J Neuroimmunol 1996; 68: 67-76.